A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients.

Krisztina EinvagKristina StahlStephan WenningerBenedikt Schoser

Published in: Journal of neurology (2019)

These first empirical results suggest a potentially beneficial role of CBD/THC in alleviating myotonia and should encourage further research in this field including a randomized-controlled trial on larger cohorts.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported